Type 2 diabetes trials in Norway
5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- No phaseTaking peopleEffects of Medisinstart for Type 2 Diabetes
- Where
- Åfjord, Bardufoss, Bergen, Birkeland, Brandbu, Drammen, Gjøvik, Jessheim, Kløfta, Kopervik, Lena, Nesoddtangen, Oslo, Øystese, Stavanger, Stryn, Trondheim, Ulefoss
- Age
- 18 years and over
- People
- 500
- Run by
- Apokus AS
See details and how to joinNCT06273657 - Phase 3Taking peopleEASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Where
- Arendal, Bodo, Drammen, Graalum, Lorenskog, Oslo, Skedsmokorset, Stavanger, Trondheim
- Age
- 18 years and over
- People
- 11,800 worldwide
- Run by
- Boehringer Ingelheim
See details and how to joinNCT07064473 · EU 2025-521188-11-00 - No phaseTaking peopleA Pan-European Post-Authorisation Safety Study: Risk of Pancreatic Cancer Among Type 2 Diabetes Patients Who Initiated Exenatide as Compared With Those Who Initiated Other Non-Glucagon-Like Peptide 1 Receptor Agonists Based Glucose Lowering Drugs
- Where
- Bergen
- Age
- 18 years to 99 years
- People
- 24,000 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT05663515 - Phase 3Taking peopleA Safety, Tolerability, and Efficacy Study of VX-880 and VX-017 in Participants With Type 1 Diabetes
- Where
- Oslo
- Age
- 18 years to 65 years
- People
- 57 worldwide
- Run by
- Vertex Pharmaceuticals Incorporated
See details and how to joinNCT04786262 · EU 2024-513929-23-00 - No phaseTaking peopleDiaMester Pilot RCT: E-health Lifestyle Program for Type 2 Diabetes
- Where
- Oslo
- Age
- 18 years and over
- People
- 99
- Run by
- Oslo University Hospital
See details and how to joinNCT07361640